The medical device manufacturer ResMed Corp. will pay a $39.5 million settlement to end a series of false claims cases in several states, according to ResMed and the U.S. Department of Justice.

ResMed, a publicly traded company based in California, maintains that it did not break any laws. The company retained Jones Day while the federal cases were ongoing.

Five whistleblowers brought cases against ResMed in four states in recent years, including in the Eastern District of New York, the Justice Department said in a news release.

About $6.2 million in settlement money will be divided among the whistleblowers, according to the Justice Department. Another $2 million is going to the states where the cases were brought, ResMed confirmed.

ResMed will continue selling its products and doing business in the United States, according to a company statement. ResMed also entered into a Corporate Integrity Agreement with the federal Office of the Inspector General, which requires the company to implement more controls related to its pricing and sales practices.

While ResMed has not been found liable for violating the Anti-Kickback Statute, U.S. Attorney Richard Donoghue for the Eastern District of New York emphasized the severity of the allegations in a statement.

"When companies give free equipment to doctors for the sole purpose of generating business and increasing their bottom lines, federal health insurance programs should not foot the bills. This case rights that alleged wrong by ResMed," Donoghue said. "We will continue to work with our law enforcement partners to hold accountable companies that put profits before patients."

U.S. Senior District Judge Sandra Feuerstein of the Eastern District of New York dismissed the case against ResMed on Monday, according to court records. Broad terms of the settlement had already been made public, including in a ResMed earnings statement in the fall, according to ResMed.